Benchmark Initiates Coverage On Inflection Point Acq with Buy Rating, Announces Price Target of $14

Benchmark analyst Subash Chandra initiates coverage on Inflection Point Acq (NASDAQ:IPEX) with a Buy rating and announces Price Target of $14.